SR One
International · active in Europe
Series-A Above Series A
Cheque range
£800k – £100M
Stages
Series A, Above Series A
Avg deals / year
23.0
Leads rounds
Yes
HQ
London
Fund type
Venture fund
01 · Thesis & focus
SR One Capital Management is a transatlantic biotech venture capital firm that seeks to partner with who we believe to be top entrepreneurs, scientists and investment partners in an effort to build elite biotechnology companies.
02 · Recent publicly announced deals
No recent deals recorded.
03 · Similar firms
Oxford Science Enterprises£5M – £30M · Also Series-A · MedTech
Ananda Impact Ventures£5M – £15M · Also Series-A · MedTech
Gresham House Ventures£3M – £20M · Also Series-A · MedTech
b2Venture AG£700k – £20M · Also Series-A · Fintech
Novo Holdings£5M – £50M · Also Series-A · Fintech
Inovia Capital£1M – £100M · Also Series-A · Fintech
Suggest a correction — SR One
What looks wrong? We review every submission.
Prefer email? kudei@concept.vc
Refresh this card?
We re-check public sources and update stages, deals and fund news. Each card can be refreshed once a week.